Whether lithium inhibits glycogen synthase kinase (GSK)‐3β activity in vivo in humans is still an open question

E-ISSN： 1399-5618|18|5|464-467

ISSN： 1398-5647

Source： BIPOLAR DISORDERS (ELECTRONIC), Vol.18, Iss.5, 2016-08, pp. : 464-467

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effect of amyloid‐β (Aβ) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK)‐3β

NEUROPATHOLOGY & APPLIED NEUROBIOLOGY, Vol. 41, Iss. 4, 2015-06 ,pp. : 445-457

John Wiley & Sons Inc

Access to resources Recommend Favorite

Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers

By Fujimuro Masahiro Hayward S.

Journal of Molecular Medicine, Vol. 82, Iss. 4, 2004-04 ,pp. : 223-231

Springer Publishing Company

Access to resources Recommend Favorite

A novel adamantyl benzylbenzamide derivative, AP736, inhibits melanogenesis in B16F10 mouse melanoma cells via glycogen synthase kinase 3β phosphorylation

International Journal of Molecular Medicine, Vol. 36, Iss. 5, 2015-01 ,pp. : 1353-1360

Spandidos Publications

Access to resources Recommend Favorite

Glycogen synthase kinase‐3 inhibitor AR‐A014418 suppresses pancreatic cancer cell growth via inhibition of GSK‐3‐mediated Notch1 expression

HPB, Vol. 17, Iss. 9, 2015-09 ,pp. : 770-776

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection of Active Fraction of Glycogen Synthase Kinase 3β in Cancer Cells by Nonradioisotopic in vitro Kinase Assay

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 297-305

Karger

Access to resources Recommend Favorite